CNSX:TRULPharmaceuticals
Trulieve Cannabis (CNSX:TRUL): Reassessing Valuation After Major Debt Restructuring and Regulatory Tailwinds
Trulieve Cannabis (CNSX:TRUL) just overhauled its balance sheet by redeeming its 2026 senior secured notes and lining up a new 10.5% 2030 debt deal, and investors are reassessing the stock.
See our latest analysis for Trulieve Cannabis.
The refinancing news comes on the back of a sharp turnaround in sentiment, with a 7 day share price return of about 61 percent and a 30 day share price return near 75 percent. However, the 5 year total shareholder return is still deeply negative, suggesting...